Hypoallergenicity of A Whey-Based, Extensively Hydrolysed Formula Containing Two Structurally Identical Human Milk Oligosaccharides
Abstract:
To determine whether an extensively hydrolyzed formula (EHF) supplemented with two human milk oligosaccharides (HMO) was tolerated by infants with cow’s milk protein allergy (CMPA).
Methods:
A whey-based EHF (Test formula) containing 2′fucosyl-lactose (2′FL) and lacto-N-neotetraose (LNnT) was assessed for clinical hypoallergenicity and safety. The Control formula was a cur...
Tags
This article's user rating is
Authors
Professor Anna Nowak-Wegrzyn
Dr Laura Czerkies
Kemuel Reyes
Dr Barbara Collins
Dr Ralf G. Heine
Related case studies
Professor Yvan Vandeplas
Professor Christophe Dupont
Professor Yvan Vandenplas
Professor Christophe Dupont
Professor Philippe Eigenmann
Professor Arne Høst
Dr Mikael Kuitunen
Dr Carmen Ribes-Koninkx
Dr Neil Shah
Professor Hania Szajewska
Dr Andrea von Berg
Dr Rajat Mukherjee
Dr Ralf G. Heine
Dr Zhengyan Zhao
on behalf of the Chinese Investigator Team
Related Content
Herentry K, et al
Rofes L, et al
Professor Liam O'Mahony
Dr Harald Renz
Dr Elizabeth Forbes-Blom
Professor Ann Nowak-Wergrzyn
Related Products
